Skip to main content
PMVP
NASDAQ Life Sciences

PMV Pharma Narrows Q2 Loss, Plans Rezatapopt NDA in Q1 2027

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.215
Mkt Cap
$64.798M
52W Low
$1.02
52W High
$1.88
52W Position info
19% above low
Off High info
35% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

PMVP sits 19% above its 52-week low of $1.02 on light trading volume (0.3× avg).

Summary

PMV Pharmaceuticals reported a narrower Q2 net loss of $18.09 million ($0.34 per share) driven by lower R&D and G&A costs. The company completed enrollment in the Phase 2 PYNNACLE trial for rezatapopt in platinum-resistant ovarian cancer and plans an NDA submission in Q1 2027. Cash runway is expected through Q2 2027, addressing the going concern warning from the 10-Q filed today. The stock trades at $1.22 with a median analyst price target of $4.00, reflecting significant upside if the NDA progresses.

At the time of this announcement, PMVP was trading at $1.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $64.8M. The 52-week trading range was $1.02 to $1.88. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

PMVP - Latest Insights

PMVP
Nov 20, 2026, 10:30 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.20
Real-time Price: $0.7601 info
Change: -$0.4399 (-37%) info
Market Cap: $63.487M info
PMVP
Nov 10, 2026, 8:02 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.25
Real-time Price: $0.7601 info
Change: -$0.4899 (-39%) info
Market Cap: $63.487M info
PMVP
Nov 10, 2026, 8:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.26
Real-time Price: $0.7601 info
Change: -$0.4994 (-40%) info
Market Cap: $63.487M info
PMVP
Sep 01, 2026, 6:23 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.27
Real-time Price: $0.7601 info
Change: -$0.5099 (-40%) info
Market Cap: $63.487M info
PMVP
Sep 01, 2026, 6:01 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.27
Real-time Price: $0.7601 info
Change: -$0.5099 (-40%) info
Market Cap: $63.487M info